nodes	percent_of_prediction	percent_of_DWPC	metapath
Sparfloxacin—TOP2A—Epirubicin—bone cancer	0.276	0.343	CbGbCtD
Sparfloxacin—TOP2A—Doxorubicin—bone cancer	0.146	0.182	CbGbCtD
Sparfloxacin—ABCC2—Carboplatin—bone cancer	0.105	0.131	CbGbCtD
Sparfloxacin—ABCC2—Cisplatin—bone cancer	0.0897	0.112	CbGbCtD
Sparfloxacin—ABCC2—Doxorubicin—bone cancer	0.0601	0.0748	CbGbCtD
Sparfloxacin—ABCC2—Methotrexate—bone cancer	0.0582	0.0725	CbGbCtD
Sparfloxacin—ABCB1—Cisplatin—bone cancer	0.0292	0.0364	CbGbCtD
Sparfloxacin—ABCB1—Doxorubicin—bone cancer	0.0196	0.0244	CbGbCtD
Sparfloxacin—ABCB1—Methotrexate—bone cancer	0.019	0.0236	CbGbCtD
Sparfloxacin—TOP2A—Gastric Cancer Network 1—C21orf33—bone cancer	0.00676	0.16	CbGpPWpGaD
Sparfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—T—bone cancer	0.0039	0.0924	CbGpPWpGaD
Sparfloxacin—ABCC2—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00262	0.0621	CbGpPWpGaD
Sparfloxacin—ABCC2—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00246	0.0581	CbGpPWpGaD
Sparfloxacin—ABCC2—Irinotecan Pathway—CYP3A4—bone cancer	0.00168	0.0397	CbGpPWpGaD
Sparfloxacin—ABCC2—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00143	0.034	CbGpPWpGaD
Sparfloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00141	0.0334	CbGpPWpGaD
Sparfloxacin—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00123	0.0292	CbGpPWpGaD
Sparfloxacin—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00115	0.0273	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00115	0.0273	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000925	0.0219	CbGpPWpGaD
Sparfloxacin—ABCC2—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000865	0.0205	CbGpPWpGaD
Sparfloxacin—TOP2A—Idarubicin—Epirubicin—bone cancer	0.000837	0.173	CbGdCrCtD
Sparfloxacin—TOP2A—Doxorubicin—Epirubicin—bone cancer	0.000837	0.173	CbGdCrCtD
Sparfloxacin—TOP2A—Daunorubicin—Epirubicin—bone cancer	0.000837	0.173	CbGdCrCtD
Sparfloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000824	0.0195	CbGpPWpGaD
Sparfloxacin—TOP2A—Epirubicin—Doxorubicin—bone cancer	0.000775	0.16	CbGdCrCtD
Sparfloxacin—TOP2A—Idarubicin—Doxorubicin—bone cancer	0.000775	0.16	CbGdCrCtD
Sparfloxacin—TOP2A—Daunorubicin—Doxorubicin—bone cancer	0.000775	0.16	CbGdCrCtD
Sparfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—bone cancer	0.000759	0.018	CbGpPWpGaD
Sparfloxacin—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000674	0.016	CbGpPWpGaD
Sparfloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000663	0.0157	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.000655	0.0155	CbGpPWpGaD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—DHFR—bone cancer	0.000461	0.0109	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000419	0.00993	CbGpPWpGaD
Sparfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—bone cancer	0.000417	0.00988	CbGpPWpGaD
Sparfloxacin—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000407	0.00963	CbGpPWpGaD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—EGFR—bone cancer	0.000398	0.00942	CbGpPWpGaD
Sparfloxacin—Levofloxacin—CYP3A4—bone cancer	0.000398	0.509	CrCbGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—ZW10—bone cancer	0.000397	0.00939	CbGpPWpGaD
Sparfloxacin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000387	0.00917	CbGpPWpGaD
Sparfloxacin—Ciprofloxacin—CYP3A4—bone cancer	0.000384	0.491	CrCbGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000357	0.00844	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—ZW10—bone cancer	0.000355	0.0084	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000344	0.00814	CbGpPWpGaD
Sparfloxacin—TOP2A—Gastric Cancer Network 2—TP53—bone cancer	0.000334	0.00791	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000325	0.00769	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—GNA11—bone cancer	0.000313	0.00741	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—EZH2—bone cancer	0.000312	0.00738	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000301	0.00712	CbGpPWpGaD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000299	0.00708	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000296	0.007	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000292	0.00691	CbGpPWpGaD
Sparfloxacin—Osteoarthritis—Doxorubicin—bone cancer	0.00028	0.00188	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Cisplatin—bone cancer	0.00028	0.00188	CcSEcCtD
Sparfloxacin—Asthma—Methotrexate—bone cancer	0.000279	0.00187	CcSEcCtD
Sparfloxacin—Dry skin—Epirubicin—bone cancer	0.000277	0.00186	CcSEcCtD
Sparfloxacin—Abdominal pain upper—Epirubicin—bone cancer	0.000276	0.00185	CcSEcCtD
Sparfloxacin—Orthostatic hypotension—Epirubicin—bone cancer	0.000276	0.00185	CcSEcCtD
Sparfloxacin—Anorexia—Cisplatin—bone cancer	0.000276	0.00185	CcSEcCtD
Sparfloxacin—Migraine—Doxorubicin—bone cancer	0.000275	0.00185	CcSEcCtD
Sparfloxacin—Affect lability—Doxorubicin—bone cancer	0.000275	0.00185	CcSEcCtD
Sparfloxacin—Pancreatitis—Methotrexate—bone cancer	0.000274	0.00184	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—RFC1—bone cancer	0.000273	0.00645	CbGpPWpGaD
Sparfloxacin—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000272	0.00183	CcSEcCtD
Sparfloxacin—Face oedema—Doxorubicin—bone cancer	0.00027	0.00181	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—TUBB4B—bone cancer	0.000269	0.00636	CbGpPWpGaD
Sparfloxacin—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000267	0.00179	CcSEcCtD
Sparfloxacin—Pancytopenia—Methotrexate—bone cancer	0.000265	0.00178	CcSEcCtD
Sparfloxacin—Mood swings—Doxorubicin—bone cancer	0.000265	0.00178	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000264	0.00177	CcSEcCtD
Sparfloxacin—Ataxia—Doxorubicin—bone cancer	0.000263	0.00176	CcSEcCtD
Sparfloxacin—Asthma—Epirubicin—bone cancer	0.000261	0.00175	CcSEcCtD
Sparfloxacin—Dysuria—Methotrexate—bone cancer	0.000261	0.00175	CcSEcCtD
Sparfloxacin—Paraesthesia—Cisplatin—bone cancer	0.00026	0.00174	CcSEcCtD
Sparfloxacin—Dyspnoea—Cisplatin—bone cancer	0.000258	0.00173	CcSEcCtD
Sparfloxacin—Dry skin—Doxorubicin—bone cancer	0.000256	0.00172	CcSEcCtD
Sparfloxacin—Pancreatitis—Epirubicin—bone cancer	0.000256	0.00172	CcSEcCtD
Sparfloxacin—Orthostatic hypotension—Doxorubicin—bone cancer	0.000256	0.00171	CcSEcCtD
Sparfloxacin—Abdominal pain upper—Doxorubicin—bone cancer	0.000256	0.00171	CcSEcCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000255	0.00604	CbGpPWpGaD
Sparfloxacin—Photosensitivity reaction—Methotrexate—bone cancer	0.000255	0.00171	CcSEcCtD
Sparfloxacin—Angina pectoris—Epirubicin—bone cancer	0.000255	0.00171	CcSEcCtD
Sparfloxacin—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000252	0.00169	CcSEcCtD
Sparfloxacin—Decreased appetite—Cisplatin—bone cancer	0.000252	0.00169	CcSEcCtD
Sparfloxacin—Bronchitis—Epirubicin—bone cancer	0.000251	0.00169	CcSEcCtD
Sparfloxacin—Pneumonia—Methotrexate—bone cancer	0.00025	0.00168	CcSEcCtD
Sparfloxacin—Pancytopenia—Epirubicin—bone cancer	0.000248	0.00166	CcSEcCtD
Sparfloxacin—Pain—Cisplatin—bone cancer	0.000247	0.00166	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000247	0.00585	CbGpPWpGaD
Sparfloxacin—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000247	0.00166	CcSEcCtD
Sparfloxacin—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000247	0.00165	CcSEcCtD
Sparfloxacin—Dysuria—Epirubicin—bone cancer	0.000244	0.00164	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—RFC1—bone cancer	0.000244	0.00577	CbGpPWpGaD
Sparfloxacin—Stomatitis—Methotrexate—bone cancer	0.000243	0.00163	CcSEcCtD
Sparfloxacin—Conjunctivitis—Methotrexate—bone cancer	0.000242	0.00162	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000242	0.00573	CbGpPWpGaD
Sparfloxacin—Asthma—Doxorubicin—bone cancer	0.000242	0.00162	CcSEcCtD
Sparfloxacin—Sweating—Methotrexate—bone cancer	0.000239	0.0016	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Epirubicin—bone cancer	0.000239	0.0016	CcSEcCtD
Sparfloxacin—Feeling abnormal—Cisplatin—bone cancer	0.000238	0.0016	CcSEcCtD
Sparfloxacin—Haematuria—Methotrexate—bone cancer	0.000237	0.00159	CcSEcCtD
Sparfloxacin—Pancreatitis—Doxorubicin—bone cancer	0.000237	0.00159	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000236	0.00559	CbGpPWpGaD
Sparfloxacin—Angina pectoris—Doxorubicin—bone cancer	0.000236	0.00158	CcSEcCtD
Sparfloxacin—Epistaxis—Methotrexate—bone cancer	0.000235	0.00157	CcSEcCtD
Sparfloxacin—Pneumonia—Epirubicin—bone cancer	0.000234	0.00157	CcSEcCtD
Sparfloxacin—Bronchitis—Doxorubicin—bone cancer	0.000233	0.00156	CcSEcCtD
Sparfloxacin—Agranulocytosis—Methotrexate—bone cancer	0.000232	0.00156	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000231	0.00155	CcSEcCtD
Sparfloxacin—Pancytopenia—Doxorubicin—bone cancer	0.00023	0.00154	CcSEcCtD
Sparfloxacin—Body temperature increased—Cisplatin—bone cancer	0.000229	0.00153	CcSEcCtD
Sparfloxacin—Jaundice—Epirubicin—bone cancer	0.000227	0.00152	CcSEcCtD
Sparfloxacin—Stomatitis—Epirubicin—bone cancer	0.000227	0.00152	CcSEcCtD
Sparfloxacin—Urinary tract infection—Epirubicin—bone cancer	0.000227	0.00152	CcSEcCtD
Sparfloxacin—Conjunctivitis—Epirubicin—bone cancer	0.000227	0.00152	CcSEcCtD
Sparfloxacin—Dysuria—Doxorubicin—bone cancer	0.000226	0.00152	CcSEcCtD
Sparfloxacin—Haemoglobin—Methotrexate—bone cancer	0.000225	0.00151	CcSEcCtD
Sparfloxacin—Hepatitis—Methotrexate—bone cancer	0.000224	0.0015	CcSEcCtD
Sparfloxacin—Haemorrhage—Methotrexate—bone cancer	0.000224	0.0015	CcSEcCtD
Sparfloxacin—Sweating—Epirubicin—bone cancer	0.000223	0.0015	CcSEcCtD
Sparfloxacin—Haematuria—Epirubicin—bone cancer	0.000222	0.00149	CcSEcCtD
Sparfloxacin—Pharyngitis—Methotrexate—bone cancer	0.000222	0.00149	CcSEcCtD
Sparfloxacin—Photosensitivity reaction—Doxorubicin—bone cancer	0.000221	0.00148	CcSEcCtD
Sparfloxacin—Epistaxis—Epirubicin—bone cancer	0.00022	0.00147	CcSEcCtD
Sparfloxacin—ABCC2—NRF2 pathway—TGFBR2—bone cancer	0.00022	0.0052	CbGpPWpGaD
Sparfloxacin—ABCC2—NRF2 pathway—GSTP1—bone cancer	0.00022	0.0052	CbGpPWpGaD
Sparfloxacin—Sinusitis—Epirubicin—bone cancer	0.000219	0.00147	CcSEcCtD
Sparfloxacin—Agranulocytosis—Epirubicin—bone cancer	0.000217	0.00146	CcSEcCtD
Sparfloxacin—Pneumonia—Doxorubicin—bone cancer	0.000217	0.00145	CcSEcCtD
Sparfloxacin—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000214	0.00143	CcSEcCtD
Sparfloxacin—Hypersensitivity—Cisplatin—bone cancer	0.000213	0.00143	CcSEcCtD
Sparfloxacin—Erythema multiforme—Methotrexate—bone cancer	0.000211	0.00142	CcSEcCtD
Sparfloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—bone cancer	0.00021	0.00498	CbGpPWpGaD
Sparfloxacin—Haemoglobin—Epirubicin—bone cancer	0.00021	0.00141	CcSEcCtD
Sparfloxacin—Jaundice—Doxorubicin—bone cancer	0.00021	0.00141	CcSEcCtD
Sparfloxacin—Stomatitis—Doxorubicin—bone cancer	0.00021	0.00141	CcSEcCtD
Sparfloxacin—Rhinitis—Epirubicin—bone cancer	0.00021	0.00141	CcSEcCtD
Sparfloxacin—Conjunctivitis—Doxorubicin—bone cancer	0.00021	0.00141	CcSEcCtD
Sparfloxacin—Urinary tract infection—Doxorubicin—bone cancer	0.00021	0.00141	CcSEcCtD
Sparfloxacin—Haemorrhage—Epirubicin—bone cancer	0.000209	0.0014	CcSEcCtD
Sparfloxacin—Hepatitis—Epirubicin—bone cancer	0.000209	0.0014	CcSEcCtD
Sparfloxacin—Tinnitus—Methotrexate—bone cancer	0.000208	0.0014	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Epirubicin—bone cancer	0.000208	0.0014	CcSEcCtD
Sparfloxacin—Asthenia—Cisplatin—bone cancer	0.000208	0.00139	CcSEcCtD
Sparfloxacin—Pharyngitis—Epirubicin—bone cancer	0.000208	0.00139	CcSEcCtD
Sparfloxacin—Sweating—Doxorubicin—bone cancer	0.000207	0.00139	CcSEcCtD
Sparfloxacin—Oedema peripheral—Epirubicin—bone cancer	0.000206	0.00138	CcSEcCtD
Sparfloxacin—Haematuria—Doxorubicin—bone cancer	0.000206	0.00138	CcSEcCtD
Sparfloxacin—SLC22A5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000204	0.00483	CbGpPWpGaD
Sparfloxacin—Epistaxis—Doxorubicin—bone cancer	0.000203	0.00136	CcSEcCtD
Sparfloxacin—Sinusitis—Doxorubicin—bone cancer	0.000202	0.00136	CcSEcCtD
Sparfloxacin—Agranulocytosis—Doxorubicin—bone cancer	0.000201	0.00135	CcSEcCtD
Sparfloxacin—Chills—Methotrexate—bone cancer	0.000201	0.00134	CcSEcCtD
Sparfloxacin—Diarrhoea—Cisplatin—bone cancer	0.000198	0.00133	CcSEcCtD
Sparfloxacin—Erythema multiforme—Epirubicin—bone cancer	0.000198	0.00133	CcSEcCtD
Sparfloxacin—Alopecia—Methotrexate—bone cancer	0.000198	0.00132	CcSEcCtD
Sparfloxacin—Tinnitus—Epirubicin—bone cancer	0.000195	0.00131	CcSEcCtD
Sparfloxacin—Haemoglobin—Doxorubicin—bone cancer	0.000195	0.0013	CcSEcCtD
Sparfloxacin—Rhinitis—Doxorubicin—bone cancer	0.000194	0.0013	CcSEcCtD
Sparfloxacin—Hepatitis—Doxorubicin—bone cancer	0.000194	0.0013	CcSEcCtD
Sparfloxacin—Haemorrhage—Doxorubicin—bone cancer	0.000194	0.0013	CcSEcCtD
Sparfloxacin—Hypoaesthesia—Doxorubicin—bone cancer	0.000193	0.00129	CcSEcCtD
Sparfloxacin—Pharyngitis—Doxorubicin—bone cancer	0.000192	0.00129	CcSEcCtD
Sparfloxacin—Oedema peripheral—Doxorubicin—bone cancer	0.000191	0.00128	CcSEcCtD
Sparfloxacin—Dysgeusia—Methotrexate—bone cancer	0.000191	0.00128	CcSEcCtD
Sparfloxacin—Back pain—Methotrexate—bone cancer	0.000188	0.00126	CcSEcCtD
Sparfloxacin—Chills—Epirubicin—bone cancer	0.000188	0.00126	CcSEcCtD
Sparfloxacin—Arrhythmia—Epirubicin—bone cancer	0.000187	0.00125	CcSEcCtD
Sparfloxacin—Alopecia—Epirubicin—bone cancer	0.000185	0.00124	CcSEcCtD
Sparfloxacin—Vomiting—Cisplatin—bone cancer	0.000184	0.00123	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000183	0.00434	CbGpPWpGaD
Sparfloxacin—Erythema multiforme—Doxorubicin—bone cancer	0.000183	0.00123	CcSEcCtD
Sparfloxacin—Rash—Cisplatin—bone cancer	0.000182	0.00122	CcSEcCtD
Sparfloxacin—Dermatitis—Cisplatin—bone cancer	0.000182	0.00122	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Methotrexate—bone cancer	0.000181	0.00121	CcSEcCtD
Sparfloxacin—Tinnitus—Doxorubicin—bone cancer	0.00018	0.00121	CcSEcCtD
Sparfloxacin—Flatulence—Epirubicin—bone cancer	0.000179	0.0012	CcSEcCtD
Sparfloxacin—Tension—Epirubicin—bone cancer	0.000179	0.0012	CcSEcCtD
Sparfloxacin—Dysgeusia—Epirubicin—bone cancer	0.000178	0.0012	CcSEcCtD
Sparfloxacin—Nervousness—Epirubicin—bone cancer	0.000177	0.00119	CcSEcCtD
Sparfloxacin—Back pain—Epirubicin—bone cancer	0.000176	0.00118	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—CDK4—bone cancer	0.000176	0.00417	CbGpPWpGaD
Sparfloxacin—Malaise—Methotrexate—bone cancer	0.000175	0.00118	CcSEcCtD
Sparfloxacin—Vertigo—Methotrexate—bone cancer	0.000175	0.00117	CcSEcCtD
Sparfloxacin—Chills—Doxorubicin—bone cancer	0.000174	0.00116	CcSEcCtD
Sparfloxacin—Arrhythmia—Doxorubicin—bone cancer	0.000173	0.00116	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000173	0.00409	CbGpPWpGaD
Sparfloxacin—Nausea—Cisplatin—bone cancer	0.000172	0.00115	CcSEcCtD
Sparfloxacin—Alopecia—Doxorubicin—bone cancer	0.000171	0.00115	CcSEcCtD
Sparfloxacin—Cough—Methotrexate—bone cancer	0.00017	0.00114	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Epirubicin—bone cancer	0.000169	0.00113	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—DHFR—bone cancer	0.000169	0.004	CbGpPWpGaD
Sparfloxacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000169	0.00399	CbGpPWpGaD
Sparfloxacin—Convulsion—Methotrexate—bone cancer	0.000169	0.00113	CcSEcCtD
Sparfloxacin—Agitation—Epirubicin—bone cancer	0.000167	0.00112	CcSEcCtD
Sparfloxacin—Flatulence—Doxorubicin—bone cancer	0.000166	0.00111	CcSEcCtD
Sparfloxacin—Arthralgia—Methotrexate—bone cancer	0.000166	0.00111	CcSEcCtD
Sparfloxacin—Myalgia—Methotrexate—bone cancer	0.000166	0.00111	CcSEcCtD
Sparfloxacin—Chest pain—Methotrexate—bone cancer	0.000166	0.00111	CcSEcCtD
Sparfloxacin—Tension—Doxorubicin—bone cancer	0.000165	0.00111	CcSEcCtD
Sparfloxacin—Dysgeusia—Doxorubicin—bone cancer	0.000165	0.00111	CcSEcCtD
Sparfloxacin—Malaise—Epirubicin—bone cancer	0.000164	0.0011	CcSEcCtD
Sparfloxacin—Discomfort—Methotrexate—bone cancer	0.000164	0.0011	CcSEcCtD
Sparfloxacin—Nervousness—Doxorubicin—bone cancer	0.000164	0.0011	CcSEcCtD
Sparfloxacin—Vertigo—Epirubicin—bone cancer	0.000164	0.0011	CcSEcCtD
Sparfloxacin—Back pain—Doxorubicin—bone cancer	0.000163	0.00109	CcSEcCtD
Sparfloxacin—Palpitations—Epirubicin—bone cancer	0.000161	0.00108	CcSEcCtD
Sparfloxacin—Confusional state—Methotrexate—bone cancer	0.00016	0.00107	CcSEcCtD
Sparfloxacin—Cough—Epirubicin—bone cancer	0.000159	0.00107	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Methotrexate—bone cancer	0.000159	0.00106	CcSEcCtD
Sparfloxacin—Convulsion—Epirubicin—bone cancer	0.000158	0.00106	CcSEcCtD
Sparfloxacin—Hypertension—Epirubicin—bone cancer	0.000157	0.00105	CcSEcCtD
Sparfloxacin—Ill-defined disorder—Doxorubicin—bone cancer	0.000156	0.00105	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Methotrexate—bone cancer	0.000155	0.00104	CcSEcCtD
Sparfloxacin—Chest pain—Epirubicin—bone cancer	0.000155	0.00104	CcSEcCtD
Sparfloxacin—Myalgia—Epirubicin—bone cancer	0.000155	0.00104	CcSEcCtD
Sparfloxacin—Arthralgia—Epirubicin—bone cancer	0.000155	0.00104	CcSEcCtD
Sparfloxacin—Agitation—Doxorubicin—bone cancer	0.000155	0.00104	CcSEcCtD
Sparfloxacin—Anxiety—Epirubicin—bone cancer	0.000155	0.00104	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Methotrexate—bone cancer	0.000154	0.00103	CcSEcCtD
Sparfloxacin—Discomfort—Epirubicin—bone cancer	0.000153	0.00103	CcSEcCtD
Sparfloxacin—Malaise—Doxorubicin—bone cancer	0.000152	0.00102	CcSEcCtD
Sparfloxacin—Dry mouth—Epirubicin—bone cancer	0.000152	0.00102	CcSEcCtD
Sparfloxacin—Vertigo—Doxorubicin—bone cancer	0.000151	0.00101	CcSEcCtD
Sparfloxacin—Anorexia—Methotrexate—bone cancer	0.000151	0.00101	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—DHFR—bone cancer	0.000151	0.00358	CbGpPWpGaD
Sparfloxacin—Confusional state—Epirubicin—bone cancer	0.00015	0.001	CcSEcCtD
Sparfloxacin—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000149	0.00353	CbGpPWpGaD
Sparfloxacin—Palpitations—Doxorubicin—bone cancer	0.000149	0.000998	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Epirubicin—bone cancer	0.000149	0.000996	CcSEcCtD
Sparfloxacin—Cough—Doxorubicin—bone cancer	0.000147	0.000986	CcSEcCtD
Sparfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.000146	0.00346	CbGpPWpGaD
Sparfloxacin—Convulsion—Doxorubicin—bone cancer	0.000146	0.000979	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Epirubicin—bone cancer	0.000146	0.000976	CcSEcCtD
Sparfloxacin—Hypertension—Doxorubicin—bone cancer	0.000145	0.000975	CcSEcCtD
Sparfloxacin—Tachycardia—Epirubicin—bone cancer	0.000145	0.000972	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000145	0.00097	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Epirubicin—bone cancer	0.000144	0.000963	CcSEcCtD
Sparfloxacin—Insomnia—Methotrexate—bone cancer	0.000144	0.000963	CcSEcCtD
Sparfloxacin—Arthralgia—Doxorubicin—bone cancer	0.000143	0.000962	CcSEcCtD
Sparfloxacin—Myalgia—Doxorubicin—bone cancer	0.000143	0.000962	CcSEcCtD
Sparfloxacin—Chest pain—Doxorubicin—bone cancer	0.000143	0.000962	CcSEcCtD
Sparfloxacin—Anxiety—Doxorubicin—bone cancer	0.000143	0.000958	CcSEcCtD
Sparfloxacin—Paraesthesia—Methotrexate—bone cancer	0.000143	0.000956	CcSEcCtD
Sparfloxacin—Discomfort—Doxorubicin—bone cancer	0.000142	0.00095	CcSEcCtD
Sparfloxacin—Anorexia—Epirubicin—bone cancer	0.000142	0.00095	CcSEcCtD
Sparfloxacin—Dyspnoea—Methotrexate—bone cancer	0.000142	0.000949	CcSEcCtD
Sparfloxacin—Somnolence—Methotrexate—bone cancer	0.000141	0.000947	CcSEcCtD
Sparfloxacin—Dry mouth—Doxorubicin—bone cancer	0.00014	0.000941	CcSEcCtD
Sparfloxacin—Dyspepsia—Methotrexate—bone cancer	0.00014	0.000937	CcSEcCtD
Sparfloxacin—Confusional state—Doxorubicin—bone cancer	0.000139	0.00093	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000138	0.00327	CbGpPWpGaD
Sparfloxacin—Decreased appetite—Methotrexate—bone cancer	0.000138	0.000926	CcSEcCtD
Sparfloxacin—Anaphylactic shock—Doxorubicin—bone cancer	0.000138	0.000922	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000136	0.00322	CbGpPWpGaD
Sparfloxacin—Pain—Methotrexate—bone cancer	0.000136	0.00091	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000135	0.000908	CcSEcCtD
Sparfloxacin—Thrombocytopenia—Doxorubicin—bone cancer	0.000135	0.000903	CcSEcCtD
Sparfloxacin—Insomnia—Epirubicin—bone cancer	0.000134	0.000901	CcSEcCtD
Sparfloxacin—Tachycardia—Doxorubicin—bone cancer	0.000134	0.0009	CcSEcCtD
Sparfloxacin—Paraesthesia—Epirubicin—bone cancer	0.000133	0.000895	CcSEcCtD
Sparfloxacin—Hyperhidrosis—Doxorubicin—bone cancer	0.000133	0.000891	CcSEcCtD
Sparfloxacin—Dyspnoea—Epirubicin—bone cancer	0.000133	0.000888	CcSEcCtD
Sparfloxacin—Somnolence—Epirubicin—bone cancer	0.000132	0.000886	CcSEcCtD
Sparfloxacin—Anorexia—Doxorubicin—bone cancer	0.000131	0.000879	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000131	0.0031	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Methotrexate—bone cancer	0.000131	0.000877	CcSEcCtD
Sparfloxacin—Dyspepsia—Epirubicin—bone cancer	0.000131	0.000877	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Methotrexate—bone cancer	0.00013	0.000871	CcSEcCtD
Sparfloxacin—Decreased appetite—Epirubicin—bone cancer	0.000129	0.000866	CcSEcCtD
Sparfloxacin—Constipation—Epirubicin—bone cancer	0.000127	0.000852	CcSEcCtD
Sparfloxacin—Pain—Epirubicin—bone cancer	0.000127	0.000852	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—CHEK2—bone cancer	0.000126	0.00299	CbGpPWpGaD
Sparfloxacin—Urticaria—Methotrexate—bone cancer	0.000126	0.000846	CcSEcCtD
Sparfloxacin—Abdominal pain—Methotrexate—bone cancer	0.000126	0.000842	CcSEcCtD
Sparfloxacin—Body temperature increased—Methotrexate—bone cancer	0.000126	0.000842	CcSEcCtD
Sparfloxacin—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000125	0.00084	CcSEcCtD
Sparfloxacin—Insomnia—Doxorubicin—bone cancer	0.000124	0.000834	CcSEcCtD
Sparfloxacin—Paraesthesia—Doxorubicin—bone cancer	0.000123	0.000828	CcSEcCtD
Sparfloxacin—Dyspnoea—Doxorubicin—bone cancer	0.000123	0.000822	CcSEcCtD
Sparfloxacin—Feeling abnormal—Epirubicin—bone cancer	0.000122	0.000821	CcSEcCtD
Sparfloxacin—Somnolence—Doxorubicin—bone cancer	0.000122	0.00082	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Epirubicin—bone cancer	0.000122	0.000815	CcSEcCtD
Sparfloxacin—Dyspepsia—Doxorubicin—bone cancer	0.000121	0.000812	CcSEcCtD
Sparfloxacin—Decreased appetite—Doxorubicin—bone cancer	0.00012	0.000801	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000118	0.0028	CbGpPWpGaD
Sparfloxacin—Urticaria—Epirubicin—bone cancer	0.000118	0.000792	CcSEcCtD
Sparfloxacin—Pain—Doxorubicin—bone cancer	0.000118	0.000788	CcSEcCtD
Sparfloxacin—Constipation—Doxorubicin—bone cancer	0.000118	0.000788	CcSEcCtD
Sparfloxacin—Abdominal pain—Epirubicin—bone cancer	0.000117	0.000788	CcSEcCtD
Sparfloxacin—Body temperature increased—Epirubicin—bone cancer	0.000117	0.000788	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000117	0.00278	CbGpPWpGaD
Sparfloxacin—Hypersensitivity—Methotrexate—bone cancer	0.000117	0.000784	CcSEcCtD
Sparfloxacin—Asthenia—Methotrexate—bone cancer	0.000114	0.000764	CcSEcCtD
Sparfloxacin—TOP2A—Circadian rythm related genes—JUN—bone cancer	0.000113	0.00269	CbGpPWpGaD
Sparfloxacin—Feeling abnormal—Doxorubicin—bone cancer	0.000113	0.00076	CcSEcCtD
Sparfloxacin—Gastrointestinal pain—Doxorubicin—bone cancer	0.000112	0.000754	CcSEcCtD
Sparfloxacin—Pruritus—Methotrexate—bone cancer	0.000112	0.000753	CcSEcCtD
Sparfloxacin—Hypersensitivity—Epirubicin—bone cancer	0.00011	0.000734	CcSEcCtD
Sparfloxacin—Urticaria—Doxorubicin—bone cancer	0.000109	0.000732	CcSEcCtD
Sparfloxacin—Abdominal pain—Doxorubicin—bone cancer	0.000109	0.000729	CcSEcCtD
Sparfloxacin—Body temperature increased—Doxorubicin—bone cancer	0.000109	0.000729	CcSEcCtD
Sparfloxacin—Diarrhoea—Methotrexate—bone cancer	0.000109	0.000728	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle—BRCA2—bone cancer	0.000107	0.00253	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000107	0.00253	CbGpPWpGaD
Sparfloxacin—Asthenia—Epirubicin—bone cancer	0.000107	0.000715	CcSEcCtD
Sparfloxacin—Pruritus—Epirubicin—bone cancer	0.000105	0.000705	CcSEcCtD
Sparfloxacin—Dizziness—Methotrexate—bone cancer	0.000105	0.000704	CcSEcCtD
Sparfloxacin—Diarrhoea—Epirubicin—bone cancer	0.000102	0.000682	CcSEcCtD
Sparfloxacin—Hypersensitivity—Doxorubicin—bone cancer	0.000101	0.000679	CcSEcCtD
Sparfloxacin—Vomiting—Methotrexate—bone cancer	0.000101	0.000677	CcSEcCtD
Sparfloxacin—Rash—Methotrexate—bone cancer	0.0001	0.000671	CcSEcCtD
Sparfloxacin—Dermatitis—Methotrexate—bone cancer	0.0001	0.000671	CcSEcCtD
Sparfloxacin—Headache—Methotrexate—bone cancer	9.95e-05	0.000667	CcSEcCtD
Sparfloxacin—Asthenia—Doxorubicin—bone cancer	9.87e-05	0.000661	CcSEcCtD
Sparfloxacin—Dizziness—Epirubicin—bone cancer	9.83e-05	0.000659	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	9.74e-05	0.00231	CbGpPWpGaD
Sparfloxacin—Pruritus—Doxorubicin—bone cancer	9.73e-05	0.000652	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	9.6e-05	0.00227	CbGpPWpGaD
Sparfloxacin—Vomiting—Epirubicin—bone cancer	9.45e-05	0.000634	CcSEcCtD
Sparfloxacin—Nausea—Methotrexate—bone cancer	9.43e-05	0.000632	CcSEcCtD
Sparfloxacin—Diarrhoea—Doxorubicin—bone cancer	9.41e-05	0.000631	CcSEcCtD
Sparfloxacin—Rash—Epirubicin—bone cancer	9.37e-05	0.000628	CcSEcCtD
Sparfloxacin—Dermatitis—Epirubicin—bone cancer	9.36e-05	0.000628	CcSEcCtD
Sparfloxacin—Headache—Epirubicin—bone cancer	9.31e-05	0.000624	CcSEcCtD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	9.29e-05	0.0022	CbGpPWpGaD
Sparfloxacin—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	9.1e-05	0.00215	CbGpPWpGaD
Sparfloxacin—Dizziness—Doxorubicin—bone cancer	9.09e-05	0.00061	CcSEcCtD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—bone cancer	8.88e-05	0.0021	CbGpPWpGaD
Sparfloxacin—Nausea—Epirubicin—bone cancer	8.83e-05	0.000592	CcSEcCtD
Sparfloxacin—Vomiting—Doxorubicin—bone cancer	8.74e-05	0.000586	CcSEcCtD
Sparfloxacin—Rash—Doxorubicin—bone cancer	8.67e-05	0.000581	CcSEcCtD
Sparfloxacin—Dermatitis—Doxorubicin—bone cancer	8.66e-05	0.000581	CcSEcCtD
Sparfloxacin—Headache—Doxorubicin—bone cancer	8.62e-05	0.000578	CcSEcCtD
Sparfloxacin—Nausea—Doxorubicin—bone cancer	8.17e-05	0.000548	CcSEcCtD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	8.14e-05	0.00193	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	8.12e-05	0.00192	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—CDK4—bone cancer	7.94e-05	0.00188	CbGpPWpGaD
Sparfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	7.8e-05	0.00185	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle, Mitotic—RB1—bone cancer	7.72e-05	0.00183	CbGpPWpGaD
Sparfloxacin—TOP2A—Circadian rythm related genes—TP53—bone cancer	7.49e-05	0.00177	CbGpPWpGaD
Sparfloxacin—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	7.01e-05	0.00166	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—RB1—bone cancer	6.9e-05	0.00163	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NDUFA12—bone cancer	6.35e-05	0.0015	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	6.04e-05	0.00143	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—MDM2—bone cancer	5.88e-05	0.00139	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—NT5C3A—bone cancer	5.26e-05	0.00125	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	4.48e-05	0.00106	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	4.31e-05	0.00102	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.89e-05	0.000921	CbGpPWpGaD
Sparfloxacin—TOP2A—Cell Cycle—TP53—bone cancer	3.38e-05	0.000799	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	3.06e-05	0.000724	CbGpPWpGaD
Sparfloxacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.57e-05	0.000608	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—ENO2—bone cancer	2.3e-05	0.000545	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—DHFR—bone cancer	2.14e-05	0.000506	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GNA11—bone cancer	2e-05	0.000473	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—CYP3A4—bone cancer	1.81e-05	0.000429	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—GSTP1—bone cancer	1.55e-05	0.000367	CbGpPWpGaD
Sparfloxacin—ABCB1—Metabolism—PTGS2—bone cancer	8.02e-06	0.00019	CbGpPWpGaD
